Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary
Launched by KU LEUVEN · Feb 15, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping patients with rectal cancer who experience bowel issues after treatment. Specifically, it aims to create a personalized bowel diary that can track and evaluate various bowel symptoms in patients who have undergone surgery known as low anterior resection. This surgery and the accompanying treatments can lead to ongoing bowel problems that affect daily life, sometimes lasting over a year. By developing this diary, researchers hope to better understand these symptoms and improve care for patients.
To participate in the trial, individuals must be at least 18 years old, have a confirmed diagnosis of rectal cancer, and be able to read and communicate in Dutch. Participants will need to give their consent before joining the study. Those who have had certain types of previous surgeries or have specific health conditions affecting bowel function may not be eligible. If you join, you can expect to help researchers gather important information that could lead to better management of bowel symptoms for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures.
- • At least 18 years of age at the time of signing the Informed Consent Form (ICF).
- • Proficient in reading, comprehending, and conversing in Dutch .
- • Patients diagnosed with a rectal tumour based on a pathology report.
- Exclusion Criteria:
- • The participant has undergone a different type of surgery, including a Hartmann procedure, abdominoperineal excision, transanal endoscopic microsurgery, or sigmoid resection.
- • Experienced fecal incontinence prior to undergoing surgery.
- • Are affected by neurological disorders affecting bowel function.
- • Already underwent previous pelvic surgery, previous pelvic radiation or rectal surgery for non-cancer reasons.
About Ku Leuven
KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Leuven, Vlaams Brabant, Belgium
Patients applied
Trial Officials
Inge Geraerts, PhD
Principal Investigator
KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported